title: Generic substitution--is it safe in patients at high cardiovascular risk?
authors.affiliation: Department of Medicine, University of Cape Town.
authors.forename: Brian
authors.initials: B
authors.lastname: Rayner
authors.forename: Biddy
authors.initials: B
authors.lastname: Buchanan-Lee
authors.forename: Johan
authors.initials: J
authors.lastname: Brink
authors.forename: Lionel
authors.initials: L
authors.lastname: Opie
mesh_terms: D000368:Aged; D002121:Calcium Channel Blockers / Q000009:adverse effects* / Q000493:pharmacokinetics; D002318:Cardiovascular Diseases / Q000139:chemically induced*; D016568:Drugs, Generic / Q000009:adverse effects*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D008297:Male; D008875:Middle Aged; D009543:Nifedipine / Q000009:adverse effects* / Q000493:pharmacokinetics; D012307:Risk Factors; D013810:Therapeutic Equivalency
chemical_list: D002121:Calcium Channel Blockers; D016568:Drugs, Generic; D009543:Nifedipine